RUCCI, NADIA
 Distribuzione geografica
Continente #
NA - Nord America 12.555
EU - Europa 5.489
AS - Asia 4.781
SA - Sud America 582
Continente sconosciuto - Info sul continente non disponibili 157
AF - Africa 61
OC - Oceania 11
Totale 23.636
Nazione #
US - Stati Uniti d'America 12.372
SG - Singapore 1.930
IT - Italia 1.238
CN - Cina 1.158
RU - Federazione Russa 1.034
IE - Irlanda 963
DE - Germania 548
TR - Turchia 547
BR - Brasile 507
HK - Hong Kong 446
VN - Vietnam 405
SE - Svezia 358
GB - Regno Unito 357
UA - Ucraina 310
FR - Francia 252
FI - Finlandia 194
CA - Canada 101
IN - India 79
NL - Olanda 56
BD - Bangladesh 48
JP - Giappone 42
PL - Polonia 33
MX - Messico 30
BE - Belgio 25
AR - Argentina 23
ES - Italia 22
AT - Austria 21
LT - Lituania 21
ZA - Sudafrica 21
CZ - Repubblica Ceca 17
IQ - Iraq 14
MA - Marocco 14
EC - Ecuador 13
KR - Corea 13
ID - Indonesia 12
VE - Venezuela 12
PK - Pakistan 11
AE - Emirati Arabi Uniti 10
AU - Australia 9
HN - Honduras 9
UZ - Uzbekistan 9
CO - Colombia 8
EG - Egitto 8
JM - Giamaica 8
SA - Arabia Saudita 7
CL - Cile 6
GT - Guatemala 6
KE - Kenya 6
MY - Malesia 6
PY - Paraguay 6
RO - Romania 6
AZ - Azerbaigian 5
CR - Costa Rica 5
EE - Estonia 5
GR - Grecia 5
IL - Israele 5
JO - Giordania 5
TT - Trinidad e Tobago 5
DO - Repubblica Dominicana 4
PA - Panama 4
CH - Svizzera 3
DZ - Algeria 3
KZ - Kazakistan 3
MK - Macedonia 3
NP - Nepal 3
PR - Porto Rico 3
PT - Portogallo 3
TH - Thailandia 3
TN - Tunisia 3
BB - Barbados 2
BG - Bulgaria 2
BH - Bahrain 2
BO - Bolivia 2
CW - ???statistics.table.value.countryCode.CW??? 2
DK - Danimarca 2
EU - Europa 2
GP - Guadalupe 2
KG - Kirghizistan 2
KW - Kuwait 2
LB - Libano 2
LV - Lettonia 2
NI - Nicaragua 2
PE - Perù 2
PH - Filippine 2
RS - Serbia 2
SN - Senegal 2
TW - Taiwan 2
UY - Uruguay 2
XK - ???statistics.table.value.countryCode.XK??? 2
AM - Armenia 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
GA - Gabon 1
GE - Georgia 1
HR - Croazia 1
IM - Isola di Man 1
IR - Iran 1
IS - Islanda 1
LC - Santa Lucia 1
Totale 23.472
Città #
Dallas 3.262
Jacksonville 1.205
Singapore 1.140
Chandler 1.039
San Jose 1.012
Dublin 962
Ashburn 823
Council Bluffs 545
Santa Clara 446
Hong Kong 439
Boardman 435
Izmir 261
Nanjing 240
San Mateo 227
New York 226
The Dalles 222
Milan 197
L’Aquila 188
Wilmington 169
Lawrence 165
Princeton 165
Moscow 158
Beijing 133
Lauterbourg 123
Ho Chi Minh City 118
Rome 107
Ann Arbor 106
Los Angeles 103
Hanoi 89
Nanchang 85
São Paulo 72
L'aquila 67
Munich 61
Hefei 55
Shenyang 53
Seattle 49
Dong Ket 48
Woodbridge 47
Tianjin 45
Guangzhou 43
Bremen 42
Tokyo 41
Hebei 40
Verona 39
Amsterdam 37
Naples 35
Toronto 35
Kitzingen 33
Kunming 32
Chicago 31
Des Moines 31
Shanghai 31
Brooklyn 29
Miano 29
Montreal 29
Mountain View 29
Orem 29
Falkenstein 28
Jiaxing 28
Phoenix 28
Columbus 27
Norwalk 26
Warsaw 26
Brussels 24
Chennai 24
Frankfurt am Main 24
Turku 24
Atlanta 23
Jinan 23
Helsinki 22
San Francisco 22
Da Nang 19
Dearborn 19
Falls Church 19
Philadelphia 18
Changsha 16
Pescara 16
Teramo 16
Houston 15
Lanzhou 15
London 15
Brno 14
Denver 14
Johannesburg 14
Mumbai 14
Ningbo 14
Zhengzhou 14
Bologna 13
Canicattì 13
Lappeenranta 13
Rio de Janeiro 13
Turin 13
Buffalo 12
Catania 12
Bari 11
Brasília 11
Manchester 11
Nuremberg 11
Poplar 11
Taizhou 11
Totale 16.258
Nome #
(0) Save to: more options The matrix proline/arginine-rich end leucine-rich repeat protein (PRELP) inhibits osteoclastogenesis inactivating NF-kappaB signal 3.108
Ontogeny and regulation of variant thyroid hormone receptor isoforms in developing rat testis 203
Blocking Jak/STAT signalling using tofacitinib inhibits angiogenesis in experimental arthritis 195
Biotechnological approach for systemic delivery of membrane Receptor Activator of NF-κB Ligand (RANKL) active domain into the circulation 175
TrkA alternative splicing: A regulated tumor-promoting switch in human neuroblastoma 173
Interleukin-1β, lipocalin 2 and nitric oxide synthase 2 are mechano-responsive mediators of mouse and human endothelial cell-osteoblast crosstalk 170
RNA interference therapy for autosomal dominant osteopetrosis type 2. Towards the preclinical development 166
Characterization of the osteoblast-like cell phenotype under microgravity conditions in the NASA-approved Rotating Wall Vessel bioreactor (RWV) 164
Anabolic and antiresorptive modulation of bone homeostasis by the epigenetic modulator sulforaphane, a naturally occurring isothiocyanate 162
A COMPLEX ROLE FOR LIPOCALIN 2 IN BONE METABOLISM: GLOBAL ABLATION IN MICE INDUCES OSTEOPENIA CAUSED BY AN ALTERED ENERGY METABOLISM 160
Effects of osteoblast-derived extracellular vesicles on aggressiveness, redox status and mitochondrial bioenergetics of MNNG/HOS osteosarcoma cells 159
c-Src and IL-6 inhibit osteoblast differentiation and integrate IGFBP5 signalling 157
Lipocalin 2: A New Mechanoresponding Gene Regulating Bone Homeostasis 157
A gene expression signature from bone metastases as predictor of clinical outcome in breast cancer patients 153
Anti-osteoblastogenic, pro-inflammatory and pro-angiogenic effect of extracellular vesicles isolated from the human osteosarcoma cell line MNNG/HOS 153
Lipocalin 2 increases after high-intensity exercise in humans and influences muscle gene expression and differentiation in mice 152
Bone cells and the mechanisms of bone remodelling 149
Pyrrolopyrimidine c-Src inhibitors reduce growth, adhesion, motility and invasion of prostate cancer cells in vitro 147
Inhibition of protein kinase c-src reduces the incidence of breast cancer metastases and increases survival in mice: Implications for therapy 147
Molecular pathogenesis of bone metastases in breast cancer: Proven and emerging therapeutic targets. 147
Non-conventional role of haemoglobin beta in breast malignancy 147
A novel protein kinase C alpha-dependent signal to ERK1/2 activated by alphaVbeta3 integrin in osteoclasts and in chinese hamster ovary (CHO) cells 146
c-Src inhibition decreases breast cancer-induced lethality and incidence of metastases in nude mice. 146
Global Transcriptome Analysis in Mouse Calvarial Osteoblasts Highlights Sets of Genes Regulated by Modeled Microgravity and Identifies A "Mechanoresponsive Osteoblast Gene Signature" 144
The "love-hate" relationship between osteoclasts and bone matrix 143
Lipocalin 2 Influences Bone and Muscle Phenotype in the MDX Mouse Model of Duchenne Muscular Dystrophy 143
Fas and Fas ligand expression in fetal and adult human testis with normal or deranged spermatogenesis 142
the effect of microgravity on osteoblast metabolism 142
The unexpected role of Hemoglobin beta (HBB) in breast cancer. 142
TRAF2 in osteotropic breast cancer cells enhances skeletal tumour growth and promotes osteolysis. 142
Extra-skeletal manifestations in mice affected by Clcn7-dependent autosomal dominant osteopetrosis type 2 clinical and therapeutic implications 142
Receptor Activator of NF-kappa B Ligand Enhances Breast Cancer-Induced Osteolytic Lesions through Upregulation of Extracellular Matrix Metalloproteinase Inducer/CD147 140
The glycosaminoglycan-binding domain of PRELP acts as a cell type-specific NF-kappaB inhibitor that impairs osteoclastogenesis 140
The α2β1 binding domain of chondroadherin inhibits breast cancer-induced bone metastases and impairs primary tumour growth: A preclinical study 140
Effective small interfering RNA therapy to treat CLCN7-dependent autosomal dominant osteopetrosis type 2 140
Transcriptomic and bioinformatic analysis of Clcn7-dependent Autosomal Dominant Osteopetrosis type 2. Preclinical and clinical implications 140
Ontogenesis and cell specific localization of Fas ligand expression in the rat testis 139
Osteoblast-conditioned media stimulate membrane vesicle shedding in prostate cancer cells 139
Osteoblast-Derived Extracellular Vesicles Are Biological Tools for the Delivery of Active Molecules to Bone 139
RNA methylation and cellular response to oxidative stress-promoting anticancer agents 138
The N-terminal domain of the bone protein PRoline/arginine-rich End Leucine-rich repeat Protein (PRELP) impairs osteoclast formation by a new mechanism inhibiting NF-kappaB signaling 138
beta-Arrestin2 Regulates RANKL and Ephrins Gene Expression in Response to Bone Remodeling in Mice 137
Paradoxical effects of JZL184, an inhibitor of monoacylglycerol lipase, on bone remodelling in healthy and cancer-bearing mice 136
Extracellular Vesicles From Osteotropic Breast Cancer Cells Affect Bone Resident Cells 136
Kinase-dependent and independent role of EphA2 in the regulation of prostate cancer invasion and metastasis 135
Small interfering RNA (siRNA) for the therapy of type 2 (ADO2) Autosomal Dominant Oosteopetrosis caused by CLCN7 (ADO2 CLCN7-dependent) gene mutation 134
Apoptosi e spermatogenesi: implicazioni fisiopatologiche 134
Increased expression of a set of genes enriched in oxygen binding function discloses a predisposition of breast cancer bone metastases to generate metastasis spread in multiple organs 132
Individualized Whole-Body Vibration: Neuromuscular, Biochemical, Muscle Damage and Inflammatory Acute Responses 132
Tyrosine kinase Src inhibitors: Cellular mechanisms for potential therapeutic applications in bone disease. 131
Notch2 pathway mediates breast cancer cellular dormancy and mobilisation in bone and contributes to haematopoietic stem cell mimicry 131
In vivo bone metastases, osteoclastogenic ability, and phenotypic characterization of human cancer cells 130
An experimental therapy to improve skeletal growth and prevent bone loss in a mouse model overexpressing IL-6 130
The C-terminal domain of chondroadherin: a new regulator of osteoclast motility counteracting bone loss 129
C-SRC inhibition decreases breast cancer-induced lethality and incidence of experimental bone metastases in Balb nu/nu mice 129
Imbalance of osteoclastogenesis-regulating factors in celiac disease 129
Lipocalin 2 serum levels correlate with age and bone turnover biomarkers in healthy subjects but not in postmenopausal osteoporotic women 129
The "soft" side of the bone: unveiling its endocrine functions. 128
Apoptosis-associated speck-like protein containing a caspase-1 recruitment domain (ASC) contributes to osteoblast differentiation and osteogenesis 127
Evaluation of metastatic potential in prostate carcinoma: An in vivo model 126
A six-gene signature predicting breast cancer lung metastasis 126
SMALL INTERFERING RNA (siRNA) FOR THE THERAPY OF TYPE 2 (ADO2) AUTOSOMAL DOMINANT OSTEOPETROSIS CAUSED BY CLCN7 (ADO2 CLCN7-DEPENDENT) GENE MUTATION 126
Reduction of c-Src activity by substituted 5,7-diphenyl-pyrrolo [2,3-d]-pyrimidines induces osteoclast apoptosis in vivo and in vitro. Involvement of ERK1/2 pathway 123
Modeled microgravity stimulates osteoclastogenesis and bone resorption by increasing osteoblast RANKL/OPG ratio 123
c-Src-mediated regulation of Penk1 signal controls osteoblast differentiation 123
Extracellular Vesicles in Bone Tumors: How to Seed in the Surroundings Molecular Information for Malignant Transformation and Progression 123
Pre-proenkephalin 1 is Downregulated Under Unloading and is Involved in Osteoblast Biology 123
Osteoblast-derived extracellular vesicles influence MNNG/HOS osteosarcoma cells, reducing their migration and affecting their metabolic activity and redox balance 123
Targeted Delivery of Lidocaine in Breast Cancer Cells via Zeolitic Imidazolate Framework‐8 Nanoparticles 122
c-Src inhibition as a possible therapy against human breast cancer and bone metastases. 122
Bone phenotype of IL-6 transgenic mice mimicking human chronic inflammatory diseases in children 122
Switching homes: how cancer moves to bone 122
A new heterozygous mutation (R714C) of the osteopetrosis gene, Pleckstrin Homolog Domain Containing Family M (With Run Domain) Member 1 (PLEKHM1), impairs vesicular acidification and increases TRACP secretion in osteoclasts 121
Bone metastasis pain, from the bench to the bedside 120
Circulating Extracellular Vesicles Express Receptor Activator of Nuclear Factor κB Ligand and Other Molecules Informative of the Bone Metabolic Status of Mouse Models of Experimentally Induced Osteoporosis 120
Editorial: Extracellular vesicles as modulators of cancer cell adaptive responses linked to therapy resistance 119
A model for in vitro three dimensional cultures of osteoblast-like cells 118
HistoEnder: a 3D printer-based histological slide autostainer that retains 3D printer functions 117
A Combined Fc-OPG/hPTH(1-34) Therapy to Restore Impaired Skeletal Growth and Bone Loss in a Mouse Model of IL-6 Dependent Juvenile Inflammatory Diseases 117
Intratumoral acidosis fosters cancer-induced bone pain through the activation of the mesenchymal tumor-associated stroma in bone metastasis from breast carcinoma 117
Bone-Targeted Doxorubicin-Loaded Nanoparticles as a Tool for the Treatment of Skeletal Metastases 117
Thyroid hormone effects on mouse oocyte maturation and granulosa cell aromatase activity 115
Bone and bone marrow: the same organ 115
Role of estrogen receptor alpha in aggressiveness and osteoclastogenic potential of human breast carcinoma cells. 115
Impaired skeletal development in interleukin-6 transgenic mice. A model for the impact of chronic inflammation on the growing skeletal system 114
Osteoclast receptors and signaling 114
Osteomimicry: how tumor cells try to deceive the bone 113
Cytokine imbalance in Celiac disease and parallel direct stimulation of osteoclastogenesis and osteoblast activity in vitro. 113
Suppression of EGF-R signaling reduces the incidence of prostate cancer metastasis in nude mice 112
inhibition of protein kinase c-Src as a therapeutic approach for cancer and bone metastases 111
Microgravity induces apoptosis and increases interleukin 6 expression in osteoblast-like cells. 111
Effectiveness Of Osteotropic Nanoparticles On Bone Metastases 111
How the "seed" prepares the "soil": The bone/bone marrow pre-metastatic niche 111
Osteopenia, decreased bone formation and impaired osteoblast development in Sox4 heterozygous mice 110
The matrix PROLINE/Arginine-Rich end leucin-rich repeat protein (PRELP) impairs osteoclastogenesis by inhibiting NF-kappaB activity 110
Alternative TrkA splicing and Cancer 109
EFFECTS OF DUAL PI3K AND mTOR INHIBITION ON INCIDENCE AND LOCAL GROWTH OF PROSTATE CANCER BONE METASTASES 109
Tumour-derived extracellular vesicles (EVs): A dangerous “message in a bottle” for bone 109
Osteoblast and osteocyte: games without frontiers 107
Expression of platelet-derived growth factor-A (PDGF-A), PDGF-B, and PDGF receptor-alpha and –beta during human testicular development and disease 106
Totale 16.323
Categoria #
all - tutte 88.738
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 88.738


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022640 0 0 0 58 38 25 20 61 70 22 79 267
2022/20232.962 202 143 29 323 315 331 12 214 1.236 21 86 50
2023/2024928 228 55 42 119 69 212 7 43 4 25 16 108
2024/20253.022 54 48 291 145 397 290 386 275 590 159 224 163
2025/20268.980 344 1.030 2.509 904 514 499 1.083 225 519 778 458 117
2026/20272.191 160 402 541 1.088 0 0 0 0 0 0 0 0
Totale 23.636